内溶性甲索特雷克萨特和在状细胞周期性癌症中新辅助治疗的新方法
S López Montalbán1, F Alarcón Soldevilla2, S Abenza Baeza1
1Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain.
Archivos de la Sociedad Espanola de Oftalmologia
|July 22, 2024
概括
作为新辅助疗法,内溶性甲醇 (MTX) 有效地降低了周期性状细胞癌 (SCC) 的大小. 这种方法被证明是安全的,没有观察到复发,为挑战SCC案件提供了一个有希望的替代方案.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 眼科医生 眼科 眼科
背景情况:
- 皮肤状细胞癌 (SCC) 带来了治疗挑战,特别是在状区域.
- 对于复杂的SCC病例,常规疗法可能是不理想的.
- 新辅助疗法正在探索改善手术结果.
关键词:
皮肤癌是因为皮肤癌,皮肤癌是因为皮肤癌.皮肤状细胞癌瘤这种癌症是皮肤癌.眼皮 眼皮 眼皮免疫疗法是一种免疫疗法.免疫疗法是一种免疫疗法.这是一种内部的新辅助剂.新增补贴 在伤口内.帕帕多斯 (Párpados) 是一个古老的城市.皮肤癌是一种皮肤癌.更多相关视频
相关概念视频
01:27Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K